Sharp Clinical Launches Direct-to-Patient Service With New Partnerships

Sharp Clinical Services, part of UDG Healthcare and a leading provider of global clinical supply services, has signed a central pharmacy partnership deal and developed a holistic patient support programme with its sister company, Ashfield.

The company has signed a partnership agreement with European central pharmacy Hubertus, Germany, which will support Sharp’s direct-to-patient logistics service for its clinical trial clients in Europe and neighboring nations.

The partnership will further enable Sharp to respond to the increasing demand for distribution direct-to-patients’ homes as part of virtual and hybrid trials which are expected to become the norm in the near future. It’s the second such agreement for Sharp, which has a similar partnership in place in the US. The agreement with Hubertus means Sharp now has the foundation to offer direct-to-patient services in the two largest markets in the world.

Sharp has also joined forces with the Patient Solutions business unit of its sister company, Ashfield. The service will provide clinical educator-led ministering in key areas such as injection training, infusions and blood pressure monitoring to patients in their own home.

This service can be delivered either through in-person visits in Europe or remotely in both the US and Europe as part of a holistic and compliant solution for clinical trial sponsors.

Company: Sharp


Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, Sharp has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. Sharp is also a world leader in ’Track and Trace’ and serialisation services, with over 11 years’ experience in implementing serialized solutions for its pharma clients.

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.